Creative Planning purchased a new stake in shares of Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) in the third quarter, Holdings Channel reports. The firm purchased 27,245 shares of the company’s stock, valued at approximately $489,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State […]
Creative Planning purchased a new stake in shares of Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) during the third quarter, Holdings Channel.com reports. The fund purchased 27,245 shares of the company’s stock, valued at approximately $489,000. A number of other large investors also recently made changes to their positions in the company. Arizona State Retirement […]
Brokerages expect Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) to post earnings per share of ($0.21) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Myovant Sciences’ earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.42). Myovant Sciences posted earnings per share of ($0.67) during the same quarter […]
Brokerages expect that Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) will announce sales of $60.06 million for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Myovant Sciences’ earnings. The lowest sales estimate is $55.50 million and the highest is $64.62 million. Myovant Sciences reported sales of $24.61 million in the […]
Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) insider Ferreira Juan Camilo Arjona sold 4,632 shares of the company’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $10.45, for a total value of $48,404.40. Following the transaction, the insider now owns 260,129 shares in the company, valued […]